UBS upgrades Embraer stock rating to Neutral on strong backlog and margins

UBS upgraded Embraer (ERJ) from Sell to Neutral and raised its price target to $69 from $44 after better-than-expected Commercial backlog, stronger margins/pricing and by folding in EVE’s market value; the stock has risen over 30% YTD. UBS values the company at about 10–11x EV/EBITDA and its 2026–2027 EBITDA forecasts run 3–5% ahead of consensus, while InvestingPro highlights improving free cash flow, dollarized revenues and Embraer’s commercial opportunity amid Boeing/Airbus supply constraints, implying potential undervaluation.

Analysis

Market Structure: The immediate winners are Embraer (ERJ/EMBJ) and its suppliers given improved commercial backlog, higher realized pricing, and UBS’s implied fair value of ~10–11x EV/EBITDA; ERJ’s YTD +30% outperformance signals re-priced regional/commuter exposure while Boeing (BA) and Tier-1 suppliers lose incremental share due to production constraints. Pricing power for Embraer should persist 6–18 months if Boeing/Airbus delivery bottlenecks continue, allowing >3–5% upside to consensus 2026–27 EBITDA embedded in UBS’s upgrade.

Risk Assessment: Key tails include a reversal of EVE valuation (private/illiquid fair-value write-down could cut equity value by 10–30%), Brazilian macro/FX shocks that hit local-cost lines, or sudden order cancellations if macro weakens — material within 3–12 months. Near-term (days–weeks) event risk: analyst revisions and orderflow releases; medium-term (3–12 months): delivery cadence and margin normalization; long-term (2+ years): competition/technology (A220-type moves) or capex strain from scaling EVE.

Trade Implications: Direct: establish a 2–3% long position in ERJ (6–12 month horizon) funded by a 1–1.5% short in BA to express regional share shift; use a stop at -15% or if backlog disclosure misses UBS’s +3–5% EBITDA delta. Options: if IV <30%, buy 9–12 month ERJ call spreads (e.g., buy Jan24/Jan25 spread) sized to target 25–50% upside; if IV >40%, sell short-dated (30–60d) calls against a small core position.

Contrarian Angles: Consensus underweights balance-sheet cadence — higher backlog can mask rising working capital and capex from EVE, creating a liquidity squeeze if deliveries slip; historical parallel: Bombardier’s regional-jet cycle where OEMs lost pricing power once a major competitor re-entered. If Airbus pivots to small/medium narrowbodies aggressively, ERJ upside could be limited; plan to trim on any >40% rally or if BRL weakens >10% in 90 days.

Key Decisions for Investors

• Establish a 2–3% long position in Embraer (ERJ) using shares or a 9–12 month call-spread (buy Jan2026 1x strike, sell higher strike to fund) targeting 30–50% upside; set stop-loss at -15% or on any public backlog below UBS assumptions.
• Fund the ERJ long by initiating a 1–1.5% short in Boeing (BA) shares for 6–12 months to express relative share gain in regional/commercial segments; cover if BA/airbus delivery guidance materially improves (>=10% increase in guided deliveries over consensus within a quarter).
• If implied volatility on ERJ <30%, buy long-dated calls (9–12 months); if IV >40%, implement defined-risk debit spreads or sell 30–60 day calls against a small core position. Size options so max loss equals the 2–3% equity allocation.
• Monitor three specific triggers in the next 30–90 days before scaling: (1) Embraer commercial backlog release vs UBS/consensus (miss >5% -> reduce), (2) any EVE valuation mark or financing event (equity or convertible issuance -> reduce), (3) BRL/USD moving >10% (weaken -> hedge local exposure or trim by 50%).